BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 38491510)

  • 1. Sex disparities revealed by single-cell and bulk sequencing and their impacts on the efficacy of immunotherapy in esophageal cancer.
    Yan H; Huang J; Li Y; Zhao B
    Biol Sex Differ; 2024 Mar; 15(1):22. PubMed ID: 38491510
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The paratumoral immune cell signature reveals the potential for the implementation of immunotherapy in esophageal carcinoma patients.
    Strizova Z; Snajdauf M; Stakheev D; Taborska P; Vachtenheim J; Biskup J; Lischke R; Bartunkova J; Smrz D
    J Cancer Res Clin Oncol; 2020 Aug; 146(8):1979-1992. PubMed ID: 32447483
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sex differences in renal cell carcinoma: a single-cell analysis reveals exhausted CD8
    Ning K; Peng Y; Jiang Y; Li Z; Luo X; Lin L; Deng M; Wu Y; Huang T; Huang Y; Xie Y; Yang X; Zhang M; Xiong L; Zou X; Zhou Z; Zhou F; Dong P; Yu C; Zhang Z
    Biol Sex Differ; 2023 Sep; 14(1):58. PubMed ID: 37715192
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A radiomics approach to assess tumour-infiltrating CD8 cells and response to anti-PD-1 or anti-PD-L1 immunotherapy: an imaging biomarker, retrospective multicohort study.
    Sun R; Limkin EJ; Vakalopoulou M; Dercle L; Champiat S; Han SR; Verlingue L; Brandao D; Lancia A; Ammari S; Hollebecque A; Scoazec JY; Marabelle A; Massard C; Soria JC; Robert C; Paragios N; Deutsch E; Ferté C
    Lancet Oncol; 2018 Sep; 19(9):1180-1191. PubMed ID: 30120041
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impacts of neoadjuvant chemoradiotherapy on the immune landscape of esophageal squamous cell carcinoma.
    Wen J; Fang S; Hu Y; Xi M; Weng Z; Pan C; Luo K; Ling Y; Lai R; Xie X; Lin X; Lin T; Chen J; Liu Q; Fu J; Yang H
    EBioMedicine; 2022 Dec; 86():104371. PubMed ID: 36434949
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular heterogeneity of anti-PD-1/PD-L1 immunotherapy efficacy is correlated with tumor immune microenvironment in East Asian patients with non-small cell lung cancer.
    Jin R; Liu C; Zheng S; Wang X; Feng X; Li H; Sun N; He J
    Cancer Biol Med; 2020 Aug; 17(3):768-781. PubMed ID: 32944405
    [No Abstract]   [Full Text] [Related]  

  • 7. Integrated single-cell and bulk sequencing analyses with experimental validation identify the prognostic and immunological implications of CD226 in pan-cancer.
    Ma P; Sun W
    J Cancer Res Clin Oncol; 2023 Nov; 149(16):14597-14617. PubMed ID: 37580402
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A fibroblast-associated signature predicts prognosis and immunotherapy in esophageal squamous cell cancer.
    Ren Q; Zhang P; Zhang X; Feng Y; Li L; Lin H; Yu Y
    Front Immunol; 2023; 14():1199040. PubMed ID: 37313409
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Integrative stemness characteristics associated with prognosis and the immune microenvironment in esophageal cancer.
    Yi L; Huang P; Zou X; Guo L; Gu Y; Wen C; Wu G
    Pharmacol Res; 2020 Nov; 161():105144. PubMed ID: 32810627
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Single-cell atlas reveals a distinct immune profile fostered by T cell-B cell crosstalk in triple negative breast cancer.
    Ding S; Qiao N; Zhu Q; Tong Y; Wang S; Chen X; Tian Q; Xiao Y; Shen K
    Cancer Commun (Lond); 2023 Jun; 43(6):661-684. PubMed ID: 37158690
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Single-Cell Transcriptomic Analysis Reveals a Tumor-Reactive T Cell Signature Associated With Clinical Outcome and Immunotherapy Response In Melanoma.
    Yan M; Hu J; Ping Y; Xu L; Liao G; Jiang Z; Pang B; Sun S; Zhang Y; Xiao Y; Li X
    Front Immunol; 2021; 12():758288. PubMed ID: 34804045
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oncolytic adenovirus decreases the proportion of TIM-3
    Liikanen I; Basnet S; Quixabeira DCA; Taipale K; Hemminki O; Oksanen M; Kankainen M; Juhila J; Kanerva A; Joensuu T; Tähtinen S; Hemminki A
    J Immunother Cancer; 2022 Feb; 10(2):. PubMed ID: 35193929
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PES1 reduces CD8
    Ma N; Hua R; Yang Y; Liu ZC; Pan J; Yu BY; Sun YF; Xie D; Wang Y; Li ZG
    J Biomed Sci; 2023 Mar; 30(1):20. PubMed ID: 36959575
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reinvigorating exhausted CD8
    Hossain MA; Liu G; Dai B; Si Y; Yang Q; Wazir J; Birnbaumer L; Yang Y
    Med Res Rev; 2021 Jan; 41(1):156-201. PubMed ID: 32844499
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of a CD8+ T cell associated signature for predicting the prognosis and immunological characteristics of gastric cancer by integrating single-cell and bulk RNA-sequencing.
    Li J; Han T; Wang X; Wang Y; Yang R; Yang Q
    Sci Rep; 2024 Feb; 14(1):4524. PubMed ID: 38402299
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immune suppressive landscape in the human esophageal squamous cell carcinoma microenvironment.
    Zheng Y; Chen Z; Han Y; Han L; Zou X; Zhou B; Hu R; Hao J; Bai S; Xiao H; Li WV; Bueker A; Ma Y; Xie G; Yang J; Chen S; Li H; Cao J; Shen L
    Nat Commun; 2020 Dec; 11(1):6268. PubMed ID: 33293583
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epigenetic modulation combined with PD-1/PD-L1 blockade enhances immunotherapy based on MAGE-A11 antigen-specific CD8+T cells against esophageal carcinoma.
    Wu Y; Sang M; Liu F; Zhang J; Li W; Li Z; Gu L; Zheng Y; Li J; Shan B
    Carcinogenesis; 2020 Jul; 41(7):894-903. PubMed ID: 32529260
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cancer immunotherapy efficacy and patients' sex: a systematic review and meta-analysis.
    Conforti F; Pala L; Bagnardi V; De Pas T; Martinetti M; Viale G; Gelber RD; Goldhirsch A
    Lancet Oncol; 2018 Jun; 19(6):737-746. PubMed ID: 29778737
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immune suppressive microenvironment in liver metastases contributes to organ-specific response of immunotherapy in advanced non-small cell lung cancer.
    Deng JY; Gou Q; Yang L; Chen ZH; Yang MY; Yang XR; Yan HH; Wei XW; Liu JQ; Su J; Zhong WZ; Xu CR; Wu YL; Zhou Q
    J Immunother Cancer; 2023 Jul; 11(7):. PubMed ID: 37463790
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of Survival and Immune-Related Biomarkers With Immunotherapy in Patients With Non-Small Cell Lung Cancer: A Meta-analysis and Individual Patient-Level Analysis.
    Yu Y; Zeng D; Ou Q; Liu S; Li A; Chen Y; Lin D; Gao Q; Zhou H; Liao W; Yao H
    JAMA Netw Open; 2019 Jul; 2(7):e196879. PubMed ID: 31290993
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.